1217207

Daneshvari Solanki, M.D. — FEI 3026907807

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
July 28, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Bellaire, TX (United States)

Additional Details

Clinical Investigator (CI)